Birth control can lower DHEA-S enough to obscure androgen testing, especially with estrogen-containing pills. A result only makes sense when the laboratory, age, medication, symptoms, and testing goal are read together.
- Combined pills commonly lower DHEA-S, so a low result while taking ethinylestradiol is not proof of adrenal failure.
- DHEA-S range is strongly age-dependent; many laboratories list roughly 83-377 µg/dL for women aged 18-30 years.
- Kõrge DHEA-S above 700 µg/dL (19.0 µmol/L) merits prompt clinician-led assessment for an adrenal source, particularly with rapid virilising symptoms.
- Progestin-only methods usually have less predictable effects on DHEA-S than combined pills because they do not consistently raise sex hormone-binding globulin.
- PCOS testing is difficult on a combined pill; the 2023 international guideline advises stopping it for at least 3 months only when biochemical androgen assessment is essential.
- Ajastus on oluline less for DHEA-S than for cortisol because DHEA-S has a long half-life, but illness, steroid medicines, supplements, and a recent contraceptive change still matter.
- Low DHEA-S on birth control is usually interpreted alongside 8 a.m. cortisol, ACTH, sodium, potassium, symptoms, and steroid exposure—not alone.
- Trendi võrdlus is most useful when the same laboratory and the same contraceptive status are used for each test.
How birth control changes DHEA-S test results
Combined hormonal contraception usually lowers DHEA-S, while progestin-only contraception has smaller and less consistent effects. An unexpectedly low value on a combined pill often reflects medication-related suppression, whereas a result above about 700 µg/dL (19.0 µmol/L) still deserves evaluation for adrenal androgen excess regardless of contraception.
DHEA-S is made predominantly by the adrenal cortex, not the ovaries, yet estrogen-containing contraception can still reduce circulating adrenal androgens. In my clinical work, the common error is treating the laboratory flag as a diagnosis rather than asking what hormonal method was present on the collection date. Dr. Thomas Klein reviews hormone panels with the prescription list open beside the result; that detail changes the interpretation surprisingly often.
A combined pill suppresses pituitary gonadotropins, raises sex hormone-binding globulin, and changes the wider androgen environment. It does not make every DHEA-S result unusable, but it can make a normal-to-low value poor evidence against pre-existing androgen excess. For a useful overview of the analyte itself, compare DHEA-S with DHEA.
Kantesti AI on an AI vereanalüüsi analüsaator that reads DHEA-S against age, reported medicines, related hormones, and previous values rather than simply repeating the laboratory high or low flag. As of August 23, 2026, no single DHEA-S number can diagnose PCOS, adrenal insufficiency, or an adrenal mass by itself.
The practical first question
Ask whether the sample was taken before starting contraception, after a formulation switch, or during stable use for at least 8-12 weeks. That timeline is usually more informative than a one-off difference of 20 µg/dL.
What the DHEA-S blood test actually measures
A DHEA-S blood test measures dehydroepiandrosterone sulfate, a stable adrenal androgen precursor. Unlike unsulfated DHEA, DHEA-S changes relatively little across a single day because its circulating half-life is about 7-10 hours.
DHEA-S is converted from DHEA by sulfotransferase activity, mainly in the zona reticularis of the adrenal cortex. Values peak in early adulthood and fall progressively thereafter; a value of 180 µg/dL may be unremarkable at age 45 but unexpectedly low or high in another age group. Laboratory ranges must therefore be age- and sex-specific.
Most laboratories report DHEA-S in µg/dL Ameerika Ühendriikides ja µmol/L elsewhere; 1 µg/dL equals approximately 0.0271 µmol/L. I have seen patients needlessly alarmed by an apparent 250-fold discrepancy when the actual issue was unit conversion. Hormone panel interpretation should always begin by confirming units.
DHEA-S is not a reliable measure of 'adrenal reserve' in a well person. A low value can occur with age, estrogen exposure, glucocorticoids, severe illness, hypopituitarism, or adrenal insufficiency, while a high value can occur with PCOS, congenital adrenal hyperplasia, medication exposure, or less often an adrenal tumour.
Why clinicians often order it
Clinicians most often use DHEA-S to help locate the source of androgen excess when acne, hirsutism, scalp-hair thinning, irregular cycles, or virilisation are present. It complements total testosterone and 17-hydroxyprogesterone; it does not replace them.
Why combined pills often lower DHEA-S
Combined pills containing estrogen and a progestin tend to reduce DHEA-S and other circulating androgens. The size of the reduction varies by formulation, baseline androgen level, body weight, and assay, so there is no correction factor that can safely be applied to an individual result.
A systematic review by Zimmerman et al. found that combined oral contraceptives substantially reduce total and free testosterone and increase sex hormone-binding globulin; many included studies also showed lower DHEA-S concentrations (Zimmerman et al., 2014). In practice, reductions around 20-40% are plausible at a population level, but an individual patient may move much more or less.
The estrogen component is usually the main reason androgen interpretation shifts. A 28-year-old taking 30 µg ethinylestradiol may have a DHEA-S of 90 µg/dL that looks concerning on paper, yet normal 8 a.m. cortisol, ACTH, electrolytes, and no steroid exposure make adrenal failure very unlikely. Her medication context is not a footnote; it is the result context.
The 2023 international PCOS guideline states that biochemical hyperandrogenism is difficult to assess on a combined oral contraceptive pill because it suppresses androgen production and raises SHBG (Teede et al., 2023). For related estrogen-test issues, see estrogen results while using contraception.
Do progestin-only methods change DHEA-S?
Progestin-only pills, implants, injections, and hormonal intrauterine systems can affect androgen symptoms, but their impact on DHEA-S is less uniform than combined pills. They do not contain estrogen, so they generally do not create the same marked SHBG rise.
A levonorgestrel intrauterine system mainly acts locally and often produces little systemic change in DHEA-S. Depot medroxyprogesterone acetate, by contrast, can suppress ovarian activity and alter the hypothalamic-pituitary-adrenal environment; interpreting a result during active injections should be cautious. The evidence is honestly thinner here than it is for combined pills.
Progestins differ in androgenic and antiandrogenic activity. This can change acne or hair growth without producing a proportional shift in DHEA-S, because DHEA-S is largely adrenal in origin. Symptoms and the prescription name matter more than assuming every 'mini-pill' behaves identically.
Kantesti AI on an AI vereanalüüsi tulemuste tõlgendamise platvorm that asks users to record the exact hormonal method and start date before comparing a DHEA-S result with older tests. A side-by-side comparison is most defensible when contraception status has not changed; our labori trendijuhend selgitab, miks.
Copper intrauterine devices
A copper intrauterine device does not contain hormones and should not directly suppress DHEA-S. If a result changes after switching from a combined pill to copper contraception, the change may represent recovery from the pill's suppressive effect rather than a new adrenal disorder.
Does pill formulation or dose make a difference?
Yes—ethinylestradiol dose and progestin type can influence androgen-related results, although DHEA-S changes cannot be predicted precisely from a packet label. A lower-estrogen pill may still suppress androgen testing enough to obscure mild hyperandrogenism.
Pills containing 20 µg versus 30-35 µg ethinylestradiol can produce different SHBG effects, but DHEA-S response is not linear enough for a clinician to 'add back' a percentage. Drospirenone and cyproterone acetate formulations may also improve androgen-mediated symptoms through receptor effects that are not visible in DHEA-S alone.
The interval after a switch matters. I generally avoid interpreting a new endocrine baseline within the first 6–8 nädala pärast after starting, stopping, or changing a combined pill unless the question is urgent. A repeat after stable exposure is more interpretable, particularly if the initial finding was only mildly outside range.
Contraception can also shift lipids and triglycerides, so hormone panels should not be read in isolation from metabolic markers. Our review of lipid changes on birth control explains the parallel issue.
Do not stop contraception for a routine result
Stopping contraception solely to make a laboratory report look cleaner can lead to unintended pregnancy, bleeding, or symptom relapse. The ordering clinician should decide whether the diagnostic value of an off-pill test exceeds those real risks.
When should DHEA-S be tested on birth control?
DHEA-S can usually be collected at any time of day and at any point in a stable pill pack, but morning sampling is preferable when cortisol or ACTH is ordered at the same time. The key timing variable is stable hormonal exposure, not a particular placebo-pill day.
DHEA-S has less dramatic diurnal variation than cortisol, but laboratories often standardise endocrine sampling between kell 7.00–10.00. to make a combined adrenal panel coherent. If cortisol is low at 4 p.m., it may be physiologic; if it is low at 8 a.m., the interpretation is different. See morning and evening cortisol values.
For people using a combined pill, a placebo-week measurement is not an off-treatment measurement. Hepatic protein changes and suppression of the hypothalamic-pituitary-ovarian axis persist beyond several placebo days. Testing during that week may falsely feel like a 'natural' hormone snapshot.
Acute viral illness, major calorie restriction, systemic glucocorticoids, and poor sleep can move adrenal-related markers. Record the collection time, last hormonal dose, recent illness, and supplements; a result without those four details is much harder to use clinically.
Fasting is usually unnecessary
DHEA-S testing generally does not require fasting. Fasting may be requested because glucose, insulin, lipids, or other tests were ordered simultaneously, not because DHEA-S itself requires an empty stomach.
DHEA-S reference ranges depend on age and laboratory
DHEA-S reference intervals decline sharply with age, so the range printed by the testing laboratory should override a generic internet range. For women aged 18-30 years, a common interval is about 83-377 µg/dL, but each assay establishes its own limits.
Mayo Clinic Laboratories lists female intervals of roughly 83-377 µg/dL at ages 18-30, 45-295 µg/dL at 31-40, 27-240 µg/dL at 41-50, and 16-195 µg/dL at 51-60. These are assay-specific reference data, not disease thresholds. Some European laboratories report lower limits in µmol/L and use different immunoassays.
A DHEA-S result just outside a reference interval is not automatically clinically abnormal. Biological variation, assay variation, and a recent change in contraception can explain a modest flag; the meaning of out-of-range results is often less dramatic than the portal colour suggests.
Kantesti AI-põhine vereanalüüsi analüüsitööriist identifies unit mismatches and age-range mismatches before suggesting follow-up questions. That is especially helpful for DHEA-S because a number copied without units can be clinically meaningless.
What a low DHEA-S result on birth control means
Low DHEA-S on a combined pill is common and is not sufficient to diagnose adrenal insufficiency. A truly concerning low result usually comes with compatible symptoms and abnormal morning cortisol, ACTH, sodium, potassium, or a history of glucocorticoid exposure.
Low DHEA-S occurs with normal ageing, oral estrogen exposure, chronic glucocorticoid treatment, pituitary disease, and primary adrenal insufficiency. There is no universal DHEA-S cutoff that confirms Addison disease. A value below the range is a clue, not a stand-alone screen.
The reason we worry about low DHEA-S combined with 8 a.m. cortisol below 3 µg/dL (83 nmol/L), high ACTH, low sodium, high potassium, weight loss, and postural symptoms is that the cluster can indicate primary adrenal insufficiency. Endocrine Society guidance recommends confirmatory corticotropin stimulation testing when clinically feasible (Bornstein et al., 2016).
A normal DHEA-S does not rule out adrenal insufficiency, and a low DHEA-S on a pill does not establish it. If fatigue is the only symptom, clinicians often first consider sleep, thyroid disease, iron deficiency, mood, and medication effects; low cortisol red flags can help distinguish urgent patterns.
High DHEA-S causes while using contraception
High DHEA-S despite combined hormonal contraception is more informative than a low result because the pill often suppresses rather than raises it. PCOS is common, but a marked elevation, rapid progression, or virilisation requires an adrenal-focused evaluation.
Common high DHEA-S causes include PCOS, non-classic congenital adrenal hyperplasia, adrenal androgen-producing disorders, and DHEA supplement use. A laboratory value over 700 µg/dL is a widely used practical threshold for considering an adrenal neoplasm, although the urgency depends on symptoms, testosterone, imaging history, and assay confirmation.
Rapidly progressive coarse facial hair, deepening voice, increased muscle mass, clitoromegaly, or new severe acne over months—not years—needs urgent medical review. These features matter because a slow pattern from puberty fits PCOS more often, whereas rapid virilisation raises concern for a tumour or severe hyperandrogenic disorder.
Before advanced imaging, I usually verify the result, ask specifically about over-the-counter DHEA (often 25–50 mg/päevas), review testosterone and 17-hydroxyprogesterone, and consider assay methodology. High testosterone patterns in women provide useful context.
Kas toidulisandid loevad?
Yes. Oral DHEA can substantially increase DHEA-S, and many patients do not list it because it is sold as a supplement rather than prescribed medicine. Stop only under clinician advice if it was recommended for a specific condition.
Can DHEA-S diagnose PCOS while on the pill?
DHEA-S cannot diagnose PCOS on or off birth control, and combined pills can make biochemical hyperandrogenism difficult to detect. PCOS is diagnosed from a pattern of ovulatory dysfunction, androgen excess, and ovarian morphology or anti-Müllerian hormone after excluding alternatives.
The 2023 international PCOS guideline advises that if biochemical androgen assessment is imperative, the combined pill should be withdrawn for a minimum of 3 kuud, with alternative contraception provided during that time (Teede et al., 2023). That is not a blanket instruction for everyone with acne or irregular past cycles. It is a targeted diagnostic decision made with a clinician.
DHEA-S is elevated in a minority of people with PCOS and may be normal even when testosterone is high. Conversely, a mildly elevated DHEA-S without irregular cycles or clinical androgen signs does not establish PCOS. The best work-up considers total testosterone, preferably a reliable assay, free androgen assessment, prolactin, thyroid testing, and 17-hydroxyprogesterone when indicated.
If your aim is to clarify a prior PCOS diagnosis, document the pre-pill history: cycle length, acne onset, hair pattern, weight change, and previous scans. Our article on PCOS testing after stopping contraception outlines the usual timing questions.
Symptoms can be treated before labels are settled
There is no need to tolerate distressing acne, hirsutism, or heavy bleeding while waiting for ideal endocrine testing. Symptom treatment and diagnostic clarification can proceed together under a clinician-led plan.
When high or low DHEA-S needs prompt follow-up
Seek prompt medical assessment for DHEA-S above 700 µg/dL, rapid virilisation, or low DHEA-S accompanied by vomiting, severe weakness, fainting, dehydration, or suspected adrenal crisis. The number alone sets the pace less often than the number plus symptoms.
A DHEA-S value above 700 µg/dL (19.0 µmol/L), especially with testosterone above the laboratory range, is usually followed by repeat testing and endocrinology assessment. Clinicians may use adrenal imaging after biochemical confirmation, rather than scanning every modest abnormality. Assay interference and supplements should be excluded first.
Possible adrenal crisis is an emergency. Severe abdominal symptoms, repeated vomiting, confusion, collapse, low blood pressure, or inability to keep fluids down warrant emergency care, particularly in someone with known adrenal disease or recent steroid withdrawal. A home hormone result should never delay urgent treatment.
Kantesti AI highlights high-risk combinations but does not diagnose adrenal disease or replace emergency assessment. Patients can see why cortisol, ACTH, electrolytes, and DHEA-S are read together in our kortisooli ja ACTH mustri juhis.
Which tests clarify an unexpected DHEA-S result
The most useful follow-up tests depend on whether DHEA-S is low or high. High results commonly prompt total testosterone, 17-hydroxyprogesterone, and medication review; low results prompt 8 a.m. cortisol, ACTH, and electrolyte assessment when symptoms support adrenal concern.
For suspected androgen excess, clinicians often repeat DHEA-S using the same laboratory, measure total testosterone by a high-quality method, and obtain 17-hydroxyprogesterone at 7-9 a.m. to screen for non-classic congenital adrenal hyperplasia. A basal 17-hydroxyprogesterone above roughly 200 ng/dL (6 nmol/L) often leads to ACTH stimulation testing, though laboratory cutoffs vary.
For possible adrenal insufficiency, simultaneous morning cortisol and ACTH are more meaningful than DHEA-S alone. The Endocrine Society considers a peak cortisol below 18 µg/dL (500 nmol/L) at 30 or 60 minutes after standard 250 µg corticotropin stimulation suggestive of adrenal insufficiency, subject to assay-specific interpretation (Bornstein et al., 2016).
Do not forget non-endocrine explanations: albumin changes, acute illness, and laboratory variation can complicate broad panels. If a result has changed abruptly, our vereanalüüsi erinevuste juhend explains why repeating under comparable conditions is often sensible.
How to prepare for a more reliable DHEA-S blood test
Reliable DHEA-S testing starts with an accurate medication and supplement list, stable contraception, and a morning collection when cortisol or ACTH is also ordered. You usually do not need to fast specifically for DHEA-S.
Tell the laboratory and clinician about combined pills, progestin-only methods, estrogen patches, steroid inhalers, prednisone, hydrocortisone, testosterone, and DHEA supplements. Even an inhaled or topical glucocorticoid can be relevant in a susceptible person if exposure is substantial or prolonged. Bring a photograph of labels if names are uncertain.
Avoid starting or stopping DHEA supplementation in the days before testing simply to influence the result. For a baseline evaluation, clinicians commonly request no DHEA for at least 48–72 tundi, but the appropriate interval depends on dose and the clinical question. Prescribed corticosteroids must never be stopped abruptly without medical advice.
Use the same laboratory for a repeat whenever possible. Different immunoassays and mass-spectrometry methods can produce non-identical results, particularly near the upper limit; blood-test timing and medication effects are worth recording with each draw.
How to compare DHEA-S results over time
A DHEA-S trend is most meaningful when age, laboratory method, contraception, supplements, and collection conditions are similar. A 25% fall after starting a combined pill may be expected, while a persistent rise across repeated stable tests deserves review.
DHEA-S naturally declines with age, so annual comparisons should be interpreted against an age-adjusted range rather than a fixed personal target. A single value of 210 µg/dL at age 27 and 165 µg/dL at age 31 can both be entirely ordinary, especially if the second test followed combined-pill initiation.
Dr. Thomas Klein has found that the most revealing note in a hormone timeline is often 'started pill 10 weeks earlier' rather than the result itself. Our data workflow compares the reported collection dates and medication changes before declaring a biomarker trend clinically meaningful.
Kantesti AI supports trend review across uploaded reports and uses laboratory-specific intervals rather than assuming every country reports DHEA-S the same way. The clinical approach behind those checks is described in our meditsiinilise valideerimise ülevaade.
Symptoms and companion hormones that change interpretation
DHEA-S interpretation changes materially when it is paired with symptoms and companion markers. High DHEA-S with rapid hair growth and high testosterone is more concerning than high DHEA-S alone; low DHEA-S with normal morning cortisol is usually less concerning.
Acne, hirsutism, and irregular cycles point toward androgen excess but do not identify its source. Testosterone is more often ovarian or mixed in origin, whereas DHEA-S is a better marker of adrenal androgen production. When both are significantly elevated, the pace of symptom change becomes particularly important.
Fatigue, low libido, and low mood are nonspecific. DHEA-S is sometimes marketed as an explanation for all three, but I would not use it that way; thyroid function, ferritin, sleep, depression, medication effects, and reproductive stage may be more actionable. See our careful review of blood tests for low libido.
Kantesti AI can organise the surrounding biomarkers for discussion, but interpretation remains a clinical conversation. Our Meditsiininõukogu helps set the escalation rules for patterns that require a physician rather than automated reassurance.
Evidence, limits, and safe next steps after your result
The safe next step after an unexpected DHEA-S result is usually confirmation and context, not self-treatment or abrupt contraceptive changes. Marked elevations, rapid virilisation, and possible adrenal-crisis symptoms need timely clinician assessment; mild isolated changes often need a planned repeat.
The best direct evidence for combined pills concerns their broad androgen-lowering effect, while evidence comparing every progestin-only formulation remains limited. Zimmerman et al. (2014) supports cautious interpretation of androgen values on combined contraception, and Teede et al. (2023) gives the practical three-month withdrawal approach only when PCOS biochemical testing is essential.
Kantesti AI on an AI laboratoorse testi tõlgendamise teenuses designed to make the medication context, units, age range, and related tests visible before a patient discusses results with a clinician. It is not an endocrine diagnostic service, and no AI output should be used to start DHEA, stop prescribed hormones, or defer urgent care. Learn how our methodology is built in the AI-tehnoloogia juhend.
For transparency, our research library also lists two Kantesti publications on coagulation and serum proteins. They are not evidence for DHEA-S or contraceptive effects and should not be used to make endocrine decisions: Klein, T. (2026). aPTT normaalne vahemik: D-dimeer, valk C vere hüübimise juhend. Zenodo. DOI, ResearchGate, Academia.edu; Klein, T. (2026). Seerumi valkude juhend: globuliinide, albumiini ja A/G suhte vereanalüüs. Zenodo. DOI, ResearchGate, Academia.edu.
Korduma kippuvad küsimused
Does birth control lower DHEA-S?
Combined estrogen-progestin birth control often lowers DHEA-S, although the change differs between people and formulations. Population studies commonly show androgen reductions in the 20-40% range, but no clinician can accurately calculate an untreated value by adding back a fixed percentage. A low DHEA-S result while using a combined pill is therefore not enough to diagnose adrenal insufficiency. If adrenal disease is suspected, clinicians usually assess 8 a.m. cortisol, ACTH, electrolytes, symptoms, and steroid exposure as well.
Can I test DHEA-S while taking the pill?
You can test DHEA-S while taking the pill, but the result must be interpreted as an on-treatment value. Combined pills can suppress androgen production and raise sex hormone-binding globulin, which may mask mild biochemical hyperandrogenism. The 2023 international PCOS guideline advises stopping a combined pill for at least 3 months only if biochemical androgen assessment is essential, with alternative contraception considered. Do not stop contraception without discussing pregnancy prevention and symptom control with your clinician.
What DHEA-S level is dangerously high in women?
A DHEA-S level above about 700 µg/dL, equivalent to approximately 19.0 µmol/L, usually warrants prompt assessment for an adrenal androgen-producing condition. The urgency rises when the result occurs with rapid coarse hair growth, deepening voice, severe new acne, increased muscle mass, or elevated testosterone. A moderately high result below 700 µg/dL is more often explained by PCOS, supplements, or assay variation, but still needs context. Repeat testing and clinician-guided companion tests commonly come before imaging.
What does low DHEA-S on birth control mean?
Low DHEA-S on combined birth control commonly reflects estrogen-related androgen suppression rather than a failing adrenal gland. There is no universal low DHEA-S threshold that diagnoses Addison disease. Concern is greater when low DHEA-S occurs with an 8 a.m. cortisol below 3 µg/dL, high ACTH, low sodium, high potassium, unintentional weight loss, or postural dizziness. Confirmatory adrenal testing should be organised by a clinician rather than based on DHEA-S alone.
Should DHEA-S be measured on a placebo-pill day?
A DHEA-S measurement during the placebo-pill week is still generally considered an on-pill result. The hormonal and hepatic protein effects of combined contraception do not disappear after a few inactive tablets. DHEA-S itself has a circulating half-life of roughly 7-10 hours, and the wider endocrine effects of contraception last longer than that. For trend testing, use a similar pill-pack phase and record the formulation and collection time.
Do DHEA supplements cause high DHEA-S?
Yes, oral DHEA supplements can raise DHEA-S substantially, including doses commonly sold as 25 mg or 50 mg daily. People often omit these products from their medication list because they are available without prescription in some countries. A clinician may ask you to pause DHEA for 48-72 hours before a planned baseline test, but the interval depends on dose and the diagnostic aim. Do not stop prescribed hormone treatment or corticosteroids without medical advice.
Hangi AI-toega vereanalüüsi analüüs juba täna
Liitu enam kui 2 miljoni kasutajaga üle maailma, kes usaldavad Kantesti-d kohese ja täpse laborianalüüsi jaoks. Laadi üles oma vereanalüüsi tulemused ja saad põhjaliku tõlgenduse 15,000+ biomarkerite kohta sekunditega.
📚 Viidatud teaduspublikatsioonid
Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T. (2026). aPTT normaalne vahemik: D-dimeeri, valk C verehüübimise juhend. Zenodo.. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T. (2026). Serum Proteins Guide: Globulins, Albumin & A/G Ratio Blood Test. Zenodo.. Kantesti AI Medical Research.
📖 Välised meditsiinilised viited
⚕️ Meditsiiniline lahtiütlus
Käesolev artikkel on mõeldud üksnes hariduslikel eesmärkidel ega kujuta endast meditsiinilist nõuannet. Diagnoosi ja ravivalikute otsuste tegemiseks konsulteeri alati kvalifitseeritud tervishoiutöötajaga.
E-E-A-T usaldussignaalid
Kogemus
Arsti juhitud kliiniline ülevaade labori tõlgendamise töövoogudest.
Ekspertiis
Laborimeditsiin keskendub sellele, kuidas biomarkerid käituvad kliinilises kontekstis.
Autoriteetsus
Kirjutanud dr Thomas Klein, ülevaade: dr Sarah Mitchell ja prof dr Hans Weber.
Usaldusväärsus
Tõenduspõhine tõlgendus selgete edasiste sammudega, et vähendada ärevust.